In a real-world clinical practice setting, the 1-h PG ≥ 155 mg/dl (8.6 mmol/l) is superior for detecting high-risk individuals compared with HbA1c. Furthermore, HbA1c is a less precise correlate of insulin sensitivity and β-cell function than the 1-h PG and correlates poorly with the 2-h PG during the OGTT (Acta Diabetologica)
Diabetes News
Category: Testing
Direct Evidence of Acetaminophen Interference with Subcutaneous Glucose Sensing in Humans: A Pilot Study
The observed interference with glucose measurements in the tested CGM devices coincided temporally with appearance of acetaminophen in the ISF. The method applied here can be used to determine the susceptibility of current and future CGM systems to interference from acetaminophen or other exogenous pharmacologic agents (Diabetes Technology and Therapeutics)
Blood ß-hydroxybutyrate vs. urine acetoacetate testing for ketoacidosis
There is evidence suggesting that blood ß-hydroxybutyrate testing is more effective than urine acetoacetate testing in reducing emergency department assessment, hospitalization and time to recovery from diabetic ketoacidosis, as well as potentially lowering healthcare expenditure. Further research in both young people and adults is needed (Diabetic Medicine)
Evaluation of a Self-Administered Oral Glucose Tolerance Test
Self-administered OGTTs can be performed successfully by untrained individuals in a community setting. With improved device reliability and appropriate calibration, this novel technology could be used in routine practice to screen people who might need a formal OGTT to confirm the presence of impaired glucose tolerance or diabetes (Diabetes Care)
Carbohydrate counting accuracy and blood glucose variability in T2D
Inaccurate carbohydrate counting is frequent and associated with higher daily blood glucose variability in adults with type 1 diabetes (Diabetes Research and Clinical Practice)
Clinical evaluation of a novel test strip technology for blood glucose
In this analysis of data from seven independent studies, OneTouch Verio test strips provide highly accurate results at hypoglycaemic BG levels (Diabetes Research and Clinical Practice)
Correlation between Blood Activin Levels & Clinical Parameters of T2D
This study indicates that measurements of activin A, B, or follistatin cannot discriminate risk for T2D in individual patients, but nonetheless suggests that the activins and follistatin might have important roles in insulin resistance and the onset and development of T2D (Experimental Diabetes Research)
A two-step screening algorithm model is an accurate strategy for detecting GD
This study demonstrates a new concept for accurate but cheap GDM screening. This approach should be further evaluated in different populations to ensure an optimised diagnostic algorithm (Diabetologia)
Measuring glucose without needle pricks
The linchpin is a biosensor engineered by Fraunhofer researchers: A tiny chip combines measurement and digital analysis – and can be radioed to a mobile device (Fraunhofer)
Differences HbA1c & oral glucose tolerance test for diagnosis glucose tolerance
HbA1c identifies a smaller proportion of prediabetic individuals and even a smaller proportion of T2DM individuals than OGTT, with no difference in IR, insulin secretion, and cardiovascular risk profile. Subjects fulfilling both diagnostic methods for prediabetes or T2DM are characterized by a worse metabolic profile (Diabetes Care)
Blood glucose testing and primary prevention of Type 2 diabetes—evaluation of the effect of evidence-based patient information
Evidence-based patient information significantly increased knowledge about elevated glucose levels, but also increased decisional conflict and critical attitude to screening and treatment options. The intention to undergo metabolic screening decreased (Diabetic Medicine)
The impact of structured blood glucose testing on attitudes toward self-management among poorly controlled, insulin-naïve patients with type 2 diabetes
Structured self-monitoring of blood glucose leads to significant increases in self-confidence and autonomous motivation associated with diabetes self-management. Changes in self-confidence are linked to changes in glycemic control and share a time-concordant relationship (Diabetes Research and Clinical Practice)